167 related articles for article (PubMed ID: 21782124)
21. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes.
Buerger H; Otterbach F; Simon R; Schäfer KL; Poremba C; Diallo R; Brinkschmidt C; Dockhorn-Dworniczak B; Boecker W
J Pathol; 1999 Dec; 189(4):521-6. PubMed ID: 10629552
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy.
Hwang N; Schiller DE; Crystal P; Maki E; McCready DR
Ann Surg Oncol; 2009 Nov; 16(11):3000-9. PubMed ID: 19603233
[TBL] [Abstract][Full Text] [Related]
24. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
25. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
[TBL] [Abstract][Full Text] [Related]
26. Familial breast carcinoma risks by morphology: a nationwide epidemiologic study from Sweden.
Hemminki K; Granström C
Cancer; 2002 Jun; 94(11):3063-70. PubMed ID: 12115398
[TBL] [Abstract][Full Text] [Related]
27. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
28. Pathologic features of breast cancers in women with previous benign breast disease.
Jacobs TW; Byrne C; Colditz G; Connolly JL; Schnitt SJ
Am J Clin Pathol; 2001 Mar; 115(3):362-9. PubMed ID: 11242792
[TBL] [Abstract][Full Text] [Related]
29. Mucinous breast lesions: diagnostic challenges.
Tan PH; Tse GM; Bay BH
J Clin Pathol; 2008 Jan; 61(1):11-9. PubMed ID: 17873114
[TBL] [Abstract][Full Text] [Related]
30. A histopathological study for evaluation of therapeutic effects of radiofrequency ablation in patients with breast cancer.
Tsuda H; Seki K; Hasebe T; Sasajima Y; Shibata T; Iwamoto E; Kinoshita T
Breast Cancer; 2011 Jan; 18(1):24-32. PubMed ID: 20862572
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Oncotype DX Recurrence Score by Histologic Types of Breast Carcinoma.
Bomeisl PE; Thompson CL; Harris LN; Gilmore HL
Arch Pathol Lab Med; 2015 Dec; 139(12):1546-9. PubMed ID: 26619027
[TBL] [Abstract][Full Text] [Related]
32. Imaging findings in mucin-containing carcinomas of the breast: correlation with pathologic features.
Conant EF; Dillon RL; Palazzo J; Ehrlich SM; Feig SA
AJR Am J Roentgenol; 1994 Oct; 163(4):821-4. PubMed ID: 8092016
[TBL] [Abstract][Full Text] [Related]
33. MR imaging of mucinous carcinoma of the breast.
Kawashima M; Tamaki Y; Nonaka T; Higuchi K; Kimura M; Koida T; Yanagita Y; Sugihara S
AJR Am J Roentgenol; 2002 Jul; 179(1):179-83. PubMed ID: 12076930
[TBL] [Abstract][Full Text] [Related]
34. Can MR Imaging contribute in characterizing well-circumscribed breast carcinomas?
Yoo JL; Woo OH; Kim YK; Cho KR; Yong HS; Seo BK; Kim A; Kang EY
Radiographics; 2010 Oct; 30(6):1689-702. PubMed ID: 21071383
[TBL] [Abstract][Full Text] [Related]
35. Invasive Lobular Carcinoma With Extracellular Mucin: Not All Mucinous Mammary Carcinomas Are Ductal!
Singh K; DiazGomez B; Wang Y; Ou J; Hansen K
Int J Surg Pathol; 2019 Feb; 27(1):55-58. PubMed ID: 30032676
[TBL] [Abstract][Full Text] [Related]
36. Metaplastic and medullary mammary carcinomas do not express mammaglobin.
Reyes C; Gomez-Fernández C; Nadji M
Am J Clin Pathol; 2012 May; 137(5):747-52. PubMed ID: 22523213
[TBL] [Abstract][Full Text] [Related]
37. An Update of Mucinous Lesions of the Breast.
Harrison BT; Dillon DA
Surg Pathol Clin; 2018 Mar; 11(1):61-90. PubMed ID: 29413660
[TBL] [Abstract][Full Text] [Related]
38. Mammary mucinous lesions: congeners, prevalence and important pathological associations.
Chinyama CN; Davies JD
Histopathology; 1996 Dec; 29(6):533-9. PubMed ID: 8971560
[TBL] [Abstract][Full Text] [Related]
39. Amount and distribution of solid and fatty tissues in the female breast and their relationship to carcinoma.
Anastassiades OT; Spiliades C; Tsakraklides E; Gogas J
Pathol Res Pract; 1983 Mar; 176(2-4):200-15. PubMed ID: 6856517
[TBL] [Abstract][Full Text] [Related]
40. Mucin expression in mucinous carcinoma and other invasive carcinomas of the breast.
Chu JS; Chang KJ
Cancer Lett; 1999 Jul; 142(1):121-7. PubMed ID: 10424790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
